Please assess the completion status of the following clinical trial:

Trial Title: A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Children suffering from primary nocturnal enuresis with no organic pathology.~* Children of either sex, not below 5 and not above 15 years of age (not below 6 years in The Netherlands and France).~* Children with a minimum of 6 wet nights in 2 weeks.~Exclusion criteria:~* Children who have previously been treated with desmopressin or other medications for nocturnal enuresis or enuresis alarms.~* Children receiving substances that are known or suspected to potentiate antidiuretic hormone, e.g. SSRI, tricyclic antidepressant drugs, chlorpromazine and carbamazepine.~* Diagnosed renal diabetes insipidus or central diabetes insipidus with an AVP (arginine vasopressin) deficiency.~* Proven urinary tract infection within the past month or a documented positive urine culture at the start of the study

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 15 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).